Using a combination of in vitro, in silico, and immunohistochemistry in clinical samples, we were able to show that ORM1 was differentially expressed in HCC tumor and non-tumor tissues, which was in accordance with the findings of previous studies. The gene discussed is ORM1; the disease is hepatocellular carcinoma.